drugset / Trial / NCT02358265
Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare CSU disease activity at the end of the follow up phase between patients that had been treated daily continuously vs. on-demand in the treatment phase
Timeline
- Start
- 2014-12
- Primary completion
- 2017-11-20
- Completion
- 2018-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rupatadine | Small molecule | 10 mg | Oral |
| Comparator | Rupatadine | Small molecule | 20 mg | Oral |